Administration Targets Foreign Drug Pricing in Upcoming Section 301 Investigation
Recently, the Trump Administration announced plans to initiate a new Section 301 investigation into foreign…
Browsing: State
Aimed Alliance Supports CA Copay Accumulator Ban
Aimed Alliance recently sent a letter to the California legislature urging for the ban of…
FDA Confirms AFPs Not Permissible Under Section 804
On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration…
Minnesota Reports $1.34 Billion in 340B Revenue
Minnesota’s second year of 340B reporting shows that Covered Entities generated at least $1.34 billion…
Aimed Alliance Urges Maryland PDAB to Protect Patient Access in UPL Deliberations
Aimed Alliance sent letters to the Maryland PDAB urging it to proceed cautiously with setting…
GLOBE Model Expected to Have Minimal Impact on Part B OOP Costs
A new analysis published by Avalere Health found that the proposed GLOBE (Global Benchmark for Efficient…
New Report – International Reference Pricing: Lessons Learned from Abroad
For decades, rising costs of health care, health insurance, and prescription drugs have been a…
Aimed Alliance Urges Reconsideration of VA PDAB Bill
Aimed Alliance recently sent a letter urging the Virginia House Labor and Commerce Committee to…
CDC Updates U.S. Childhood Immunization Schedule
On January 5, the Centers for Disease Control and Prevention (CDC) Acting Director Jim O’Neill…
Aimed Alliance Publishes Updated 2025 PDAB Resources
Aimed Alliance is pleased to share two new resources on prescription drug affordability boards (PDABs).…